TY - JOUR
T1 - Pulmonary Sarcoidosis
T2 - Prognostic Factors at Diagnosis in Patients from North of Portugal
AU - Silva, Ana Luísa
AU - Melo, Natalia
AU - Caetano Mota, Patricia
AU - Lima, Bruno
AU - Pereira, José Miguel
AU - Cunha, Rui
AU - Guimarães, Susana
AU - Souto-Moura, Conceição
AU - Morais, Antonio
N1 - Publisher Copyright:
© 2018 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología
PY - 2020/11/1
Y1 - 2020/11/1
N2 - Background: Sarcoidosis is a multisystemic granulomatous disease that affects the lungs in more than 90% of the patients. It is associated with a variable clinical course and considering all the different forms of disease presentation, there are an absence of reliable clinical prognostic markers that can predict the outcome at diagnosis. Objective: The aim of our study was to investigate prognostic factors at diagnosis in a population of sarcoidosis patients from Northern Portugal. Methods: A group of 110 patients with chronic evolution was compared with 129 patients with disease resolution regarding their clinical, radiologic and laboratorial features. Results: We found a positive association between the chronic forms and lung function impairment, radiologic stage II, lower lymphocyte CD4/CD8 and extrapulmonary disease. Löfgren syndrome and asthenia instead had a protective significant association to chronicity. Our final logistic regression model found a significant independent association between age (adjusted OR = 1.06), extrapulmonary involvement (adjusted OR = 2.68), Löfgren's syndrome (adjusted OR = 0.15) with outcome toward chronicity. Conclusions: In this first study searching for prognostic factors at diagnosis in a Northern Portuguese population, we found clinical prognosis factors that have been described in other populations that should be considered whenever sarcoidosis is identified.
AB - Background: Sarcoidosis is a multisystemic granulomatous disease that affects the lungs in more than 90% of the patients. It is associated with a variable clinical course and considering all the different forms of disease presentation, there are an absence of reliable clinical prognostic markers that can predict the outcome at diagnosis. Objective: The aim of our study was to investigate prognostic factors at diagnosis in a population of sarcoidosis patients from Northern Portugal. Methods: A group of 110 patients with chronic evolution was compared with 129 patients with disease resolution regarding their clinical, radiologic and laboratorial features. Results: We found a positive association between the chronic forms and lung function impairment, radiologic stage II, lower lymphocyte CD4/CD8 and extrapulmonary disease. Löfgren syndrome and asthenia instead had a protective significant association to chronicity. Our final logistic regression model found a significant independent association between age (adjusted OR = 1.06), extrapulmonary involvement (adjusted OR = 2.68), Löfgren's syndrome (adjusted OR = 0.15) with outcome toward chronicity. Conclusions: In this first study searching for prognostic factors at diagnosis in a Northern Portuguese population, we found clinical prognosis factors that have been described in other populations that should be considered whenever sarcoidosis is identified.
KW - Löfgren's syndrome
KW - Prognosis
KW - Pulmonary disease
KW - Sarcoidosis
UR - http://www.scopus.com/inward/record.url?scp=85058368914&partnerID=8YFLogxK
U2 - 10.1016/j.reuma.2018.10.004
DO - 10.1016/j.reuma.2018.10.004
M3 - Article
C2 - 30559057
AN - SCOPUS:85058368914
SN - 1699-258X
VL - 16
SP - 468
EP - 472
JO - Reumatologia Clinica
JF - Reumatologia Clinica
IS - 6
ER -